section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Tested in dextrose 5% in sodium chloride 0.225%.

e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

f Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

g Test performed using the formulation WITH edetate disodium.

h Tested with combination with sodium thiosulfate (Cangene Biopharma) 4 mg/mL.

i Tested with dopamine HCl (DCC) 3.2 mg/mL.

j Tested with lidocaine HCl (AB) 8 mg/mL.

k Tested with nitroglycerin (LY) 0.4 mg/mL.

l Tested with dobutamine HCl (LI) 4 mg/mL.